DAWN MACE: Open Payments
NPI 1629449285 · SAVANNAH, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,354 in 70 payments from 19 companies in 2025. Trend: 2023 $205 · 2024 $1,144 · 2025 $1,354
Food & beverage: $1,354
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 11 | $199 |
| Astellas Pharma US Inc | 6 | $157 |
| AstraZeneca Pharmaceuticals LP | 9 | $153 |
| Lilly USA, LLC | 7 | $139 |
| GlaxoSmithKline, LLC. | 6 | $105 |
| PFIZER INC. | 5 | $104 |
| Amgen Inc. | 4 | $90 |
| Dexcom, Inc. | 5 | $84 |
| ABBVIE INC. | 3 | $73 |
| Novartis Pharmaceuticals Corporation | 2 | $42 |
Products named: Veozah, MOUNJARO, AIRSUPRA, Dexcom G6 Transmitter, KRYSTEXXA, Ozempic, ELIQUIS, SHINGRIX.
Industry payments across GA — which companies pay providers there.
